SCNI ($SCNI) Insider Trading & Smart Money Activity

SCNI · Biotechnology · Latest filing Jun 16, 2026

$SCNI has 2 insider trades on file. Insiders filed 2 Form 4 transactions in the last 12 months, none of them open-market purchases or sales.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
0
Net insider $ (12 mo)
$0
Congress trades (12 mo)
0
13F moves on file
0
Analyst ratings on file
0

SCNI insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 0 0 0 / 0 0 / 0
Q3 2026 0 0 0 / 0 0 / 0
Q4 2026 0 0 0 / 0 0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All SCNI insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
Insider Amir ReichmanChief Executive Officer Buy (Grant or award) 400M sh -17.6%-26.8% Read
Insider Mark Germain Buy (Grant or award) 120M sh -17.6%-26.8% Read

1W / 1M / 6M = how SCNI moved from the trade or filing date.

Insider trading in SCNI: who is buying and selling

InsiderRoleTradesOpen-market netShares heldLast trade
Amir Reichman Chief Executive Officer 1 — Jun 16, 2026
Mark Germain 1 — Jun 16, 2026

Frequently asked questions

What is the latest insider trade in SCNI?

Amir Reichman, Chief Executive Officer filed a buy (grant or award) of 400M sh on Jun 16, 2026.

Other biotechnology stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text